If just 1 director would invest , the price would close on double imo. But not one has since the company went on the asx. Doesn't exactly I still much confidence. Quite the opposite.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025